In this study, we found that in a large cohort of 638 patients with HCC, PKM2 expression was markedly increased and closely correlated with malignance clinical characteristics, including higher serum α-Fetoprotein level, advanced clinical stage, vascular invasion as well as tumor size. This evidence concerns the gene PKM and hepatocellular carcinoma.